Why hair turns gray: the follicle's pigment system

Where the color in hair comes from

The color of a strand of hair comes from a pigment called melanin, which is produced by specialized cells known as melanocytes. In the scalp, these pigment-producing melanocytes sit at the base of each follicle, in and around the hair bulb, where the growing hair is actively being built. Researchers often refer to this collection of pigment cells and their surroundings as the follicular pigmentary unit. There are two main forms of the pigment: eumelanin, which is associated with brown and black tones, and pheomelanin, which is associated with red and yellow tones. The overall shade of a person's hair is understood to reflect both the total amount of melanin present and the ratio between these two forms.

Melanin is not made in one step. It is synthesized inside small packages called melanosomes, through a chain of reactions that begins with the amino acid tyrosine. A central enzyme in this process is tyrosinase, which helps convert tyrosine into the intermediates that ultimately become melanin, and the whole program is coordinated by a master regulatory protein called MITF (microphthalmia-associated transcription factor). MITF is described in the research literature as a key switch that helps determine whether a melanocyte matures and turns on its pigment-making machinery.

Once melanin is packaged into melanosomes, the bulb melanocytes transfer those pigment granules to the neighboring keratinocytes — the cells that go on to form the hair shaft itself. As the shaft is pushed upward and hardens, the transferred pigment becomes locked into the growing hair. In this sense, the visible color of any segment of a strand is a record of how much pigment the follicle's pigmentary unit was depositing while that segment was being built. When less pigment is deposited, a hair looks gray; when essentially none is deposited, it looks white.

The follicle's melanocyte stem cell reserve

The pigment-producing melanocytes down in the hair bulb are not permanent fixtures. They are working cells that get used up, and for a follicle to keep making pigmented hair over many years, they have to be replenished. That replenishment is understood to come from a reserve of melanocyte stem cells (often abbreviated McSCs), which are housed higher up in the follicle, in a region commonly described as the bulge and the area just below it — part of the follicle's lower permanent portion. This region acts as a niche, a protected local environment that helps keep the stem cells in reserve.

Melanocyte stem cells are undifferentiated and largely quiescent, meaning they sit in a resting, unspecialized state until they are called upon. When the follicle needs new pigment cells, these stem cells are understood to self-renew and to produce daughter cells that travel down toward the bulb and mature into fully active, pigment-making melanocytes. This maturation is guided by signaling pathways studied in melanocyte biology — including Wnt/beta-catenin signaling and the MITF program described earlier — and by cross-talk with the neighboring hair follicle stem cells, so that the supply of pigment cells is coordinated with the production of the hair itself.

Framed simply, the melanocyte stem cell reserve is the follicle's pigment supply chain. Each time a new hair is built, fresh pigment cells are drawn from this finite pool. Because of that arrangement, the number and health of a follicle's melanocyte stem cells are understood to be central to whether it can keep turning out pigmented hair across a lifetime. This article describes that biology in general terms; it does not describe what is happening in any particular person's follicles.

Why pigment is made only during active growth

Each follicle moves through a repeating cycle rather than growing continuously. Scientists generally describe three main phases: anagen, the active growth phase in which the hair shaft is built; catagen, a short transition phase in which the lower follicle regresses; and telogen, the resting phase, after which the old hair is released and a new anagen begins. Pigment production is tightly coupled to this cycle. Melanogenesis — the actual making and depositing of melanin — is understood to occur almost exclusively during anagen, precisely when the shaft is being constructed and can receive the pigment.

During catagen, the picture changes. Pigment production switches off, and many of the melanocytes in the bulb are understood to undergo programmed cell death, a controlled self-dismantling called apoptosis. As a result, the pigmentary unit is largely taken apart at the end of each growth phase. When the next anagen begins, the follicle has to rebuild that unit essentially from scratch, drawing on its melanocyte stem cell reserve: stem cells proliferate, their descendants migrate down to the bulb, mature into working melanocytes, and switch their tyrosinase and MITF program back on so that pigment and hair growth restart together.

This cyclic teardown and rebuild is a normal part of follicle biology, but it means the pigment system is repeatedly stressed and repeatedly dependent on the stem cell pool. Because pigmentation has to be re-established from the reserve at the start of every cycle, any decline in that reserve or in the machinery that maintains it tends to show up gradually — cycle by cycle, and follicle by follicle. That is consistent with why graying is generally described as appearing progressively over time rather than all at once, though the specifics vary widely from person to person.

Why the pigment supply is understood to decline with age

Researchers generally describe age-related graying as a decline in the follicle's ability to reconstitute its pigmentary unit — that is, fewer functional pigment cells reaching the bulb over successive cycles. A central factor in the current understanding is a gradual loss or depletion of the melanocyte stem cell reserve, together with problems in how those stem cells are maintained and renewed. As the reserve is drawn down or fails to replenish itself properly, a follicle is understood to have progressively fewer pigment cells to send to the bulb, so each new hair it produces tends to carry less color than the last.

Oxidative stress is one of the mechanisms most often discussed in this context. Making and metabolizing melanin generates reactive oxygen species, and research describes an accumulation of hydrogen peroxide alongside reduced levels of protective antioxidant enzymes such as catalase in graying follicles, as well as DNA-damage responses within the pigment system. These stresses are understood to be able to push melanocyte stem cells toward premature or misplaced maturation — sometimes described as ectopic differentiation, in which stem cells turn into pigment cells while still up in the niche rather than after migrating to the bulb. When a stem cell differentiates in the wrong place, the reserve is spent without actually replacing pigment cells where they are needed.

More recent mechanistic work has described melanocyte stem cells that appear to lose their normal ability to move between follicle compartments and become effectively stuck, failing to mature into pigment-producing cells at the right time and place. Other studies point to maintenance factors — for example proteins such as Bcl2 that are tied to melanocyte stem cell survival, and the MITF program discussed earlier — whose disruption is associated with loss of the pigment reserve. These are descriptions of how the process is understood in laboratory research, not statements about any individual.

It is worth emphasizing that all of this is a general account of a biological process, not a timetable, a diagnosis, or a prediction for any particular person. The pace and pattern of graying vary enormously, and many factors beyond the ones described here are studied in relation to it. In broad terms, gray hair reflects reduced pigment output from a follicle, while white hair reflects a follicle in which essentially no functional pigment cells remain — but where any given person falls on that spectrum is not something an educational article can determine.

Genetics, pigment type, and individual variation

When and how a person's hair grays is understood to be strongly influenced by heredity, which is why graying so often tracks within families. Genome-wide studies of pigmentation have linked common variation near certain genes — for example IRF4, a gene involved in melanocyte biology and in the regulation of the MITF program — to differences in hair graying across populations. This points to the idea that the timing of graying is written, in part, into a person's genetics rather than being purely a matter of external circumstance.

Pigment type also shapes what graying looks like. Because natural color reflects a mix of eumelanin and pheomelanin, a strand that is still making some pigment but less than before can appear gray, while a strand making essentially none appears white. Since follicles cycle and change independently, pigmented and unpigmented strands are typically interspersed, which is the mechanism behind the familiar 'salt and pepper' appearance rather than a uniform fade. This is a description of how the pigment biology presents visually, not a claim about outcomes for any individual.

Beyond genetics, researchers study a range of biological factors in relation to pigmentation — among them oxidative stress, certain nutrient and cofactor pathways that feed into melanin synthesis, and the follicle's local signaling environment. The relationships involved are complex, and the scientific understanding of many of them is still developing. None of this amounts to a checklist that explains any one person's hair, and this guide should be read as background on the biology rather than as guidance about a specific situation.

This guide is educational — and how OpenDoseRx works

This article is educational and describes biology only. It is not medical advice, it does not diagnose anything, and it does not recommend any product, ingredient, or course of action for you. It is also worth noting that compounded medications are not FDA-approved drugs, and statements about them have not been evaluated by the FDA; compounded preparations are made by a licensed pharmacy to fill an individual prescription, which is a neutral fact rather than a mark of quality either way. On OpenDoseRx, the clinical decision is made by a clinician rather than by the shopper.

On OpenDoseRx, you begin by choosing a product and strength, then complete a medical intake that collects your health history and other relevant information. That intake is routed to an independent, licensed U.S. provider who reviews it and decides whether a prescription is appropriate for you — a clinical judgment, not an automatic one. If the provider determines a prescription is appropriate, it is sent to a licensed U.S. pharmacy to be filled and shipped to you; if the request is declined, you are not charged for the medication and you receive a full refund. Nothing here replaces a conversation with your own healthcare provider, who knows your full medical history and can address questions this kind of general education cannot.